(Q57254328)

https://api.crossref.org/works/10.2217%2F17410541.5.5.529

A vision for the future of genomics research

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17410541.5.5.529

Comparative validation of the Block, Willett, and National Cancer Institute food frequency questionnaires : the Eating at America's Table Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17410541.5.5.529

Methodology for adding glycemic load values to the National Cancer Institute Diet History Questionnaire database

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17410541.5.5.529

Evaluation of alternative approaches to assign nutrient values to food groups in food frequency questionnaires.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17410541.5.5.529

Cognitive research enhances accuracy of food frequency questionnaire reports: results of an experimental validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17410541.5.5.529

Is shorter always better? Relative importance of questionnaire length and cognitive ease on response rates and data quality for two dietary questionnaires

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17410541.5.5.529

Comparison of two physical activity questionnaires in obese subjects: the NUGENOB study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17410541.5.5.529

Healthy People 2010 disease prevalence in the Marshfield Clinic Personalized Medicine Research Project cohort: opportunities for public health genomic research

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17410541.5.5.529

Combinatorial pharmacogenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17410541.5.5.529

The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17410541.5.5.529

Intraocular pressure response to topical beta-blockers associated with an ADRB2 single-nucleotide polymorphism.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17410541.5.5.529

Pharmacogenetics of ophthalmic topical beta-blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17410541.5.5.529

Construction of atorvastatin dose-response relationships using data from a large population-based DNA biobank

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17410541.5.5.529

Relative impact of covariates in prescribing warfarin according to CYP2C9 genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17410541.5.5.529

Impact of age, CYP2C9 genotype and concomitant medication on the rate of rise for prothrombin time during the first 30 days of warfarin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17410541.5.5.529

A prospective, randomized pilot trial of model-based warfarin dose initiation using CYP2C9 genotype and clinical data

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17410541.5.5.529

Evaluation of genetic factors for warfarin dose prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17410541.5.5.529

CYP4F2 genetic variant alters required warfarin dose

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17410541.5.5.529

Relative impact of CYP3A genotype and concomitant medication on the severity of atorvastatin-induced muscle damage

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17410541.5.5.529

Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17410541.5.5.529